Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | January 24, 2025 05:05pm

Gainers

  • Evaxion Biotech (NASDAQ:EVAX) stock increased by 87.1% to $6.81 during Friday's pre-market session. The market value of their outstanding shares is at $39.9 million.
  • Aclarion (NASDAQ:ACON) stock moved upwards by 63.19% to $0.07. The market value of their outstanding shares is at $1.6 million.
  • Dogwood Therapeutics (NASDAQ:DWTX) shares moved upwards by 30.26% to $17.39. The market value of their outstanding shares is at $23.1 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock rose 15.45% to $6.35. The market value of their outstanding shares is at $4.4 million.
  • Avenue Therapeutics (NASDAQ:ATXI) shares moved upwards by 11.95% to $2.06. The market value of their outstanding shares is at $4.2 million.
  • Rein Therapeutics (NASDAQ:RNTX) stock increased by 11.81% to $2.46. The company's market cap stands at $53.2 million.

Losers

  • Sophia Genetics (NASDAQ:SOPH) shares fell 31.2% to $2.98 during Friday's pre-market session. The company's market cap stands at $194.8 million.
  • Jupiter Neurosciences (NASDAQ:JUNS) stock decreased by 15.18% to $1.23. The market value of their outstanding shares is at $40.7 million.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock decreased by 12.5% to $0.36. The market value of their outstanding shares is at $2.9 million.
  • Semler Scientific (NASDAQ:SMLR) stock decreased by 11.7% to $54.0. The market value of their outstanding shares is at $518.2 million.
  • Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock declined by 8.0% to $0.46. The market value of their outstanding shares is at $18.6 million.
  • Actuate Therapeutics (NASDAQ:ACTU) shares fell 7.28% to $10.2. The market value of their outstanding shares is at $199.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACON ACTU ATXI CDIO DWTX EVAX JUNS QNRX RNAZ RNTX SMLR SOPH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist